All News

The Office of Inspector General of the U.S. Department of Health & Human Services (HHS) recently announced it would investigate price increases for generic drugs in the Medicaid drug rebate program.

The pharmaceutical and healthcare industry is lauding the FDA’s approval of the first biosimilar product this year, noting that the drugs could save the U.S. healthcare system billions of dollars.

Last year, more women than men were practicing pharmacy or working in pharmacy-related careers. And there were more women managers than ever before.

Pharmacists swear an oath to do no harm. But what about patients? Should they be responsible for their behavior toward us?

Helping consumers better understand over-the-counter medications they are taking as well as freeing up pharmacists to consult with patients are the primary goals behind a new smartphone application.

Retail pharmacists are ideally situated to perform MTM through collaborative agreements with physicians, and some are making it happen.

The Food and Drug Administration (FDA) has released its lists of approved biosimilar licensed products, called the “Purple Book”. The invaluable site includes the date a biological product was licensed under the PHS Act and whether FDA evaluated the biological product for reference product exclusivity.